These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 20551058)

  • 1. Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.
    Warrington NM; Gianino SM; Jackson E; Goldhoff P; Garbow JR; Piwnica-Worms D; Gutmann DH; Rubin JB
    Cancer Res; 2010 Jul; 70(14):5717-27. PubMed ID: 20551058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatiotemporal differences in CXCL12 expression and cyclic AMP underlie the unique pattern of optic glioma growth in neurofibromatosis type 1.
    Warrington NM; Woerner BM; Daginakatte GC; Dasgupta B; Perry A; Gutmann DH; Rubin JB
    Cancer Res; 2007 Sep; 67(18):8588-95. PubMed ID: 17875698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.
    Sun T; Gianino SM; Jackson E; Piwnica-Worms D; Gutmann DH; Rubin JB
    J Neuroimmunol; 2010 Jul; 224(1-2):108-13. PubMed ID: 20554030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cyclic AMP pathway is a sex-specific modifier of glioma risk in type I neurofibromatosis patients.
    Warrington NM; Sun T; Luo J; McKinstry RC; Parkin PC; Ganzhorn S; Spoljaric D; Albers AC; Merkelson A; Stewart DR; Stevenson DA; Viskochil D; Druley TE; Forys JT; Reilly KM; Fisher MJ; Tabori U; Allen JC; Schiffman JD; Gutmann DH; Rubin JB
    Cancer Res; 2015 Jan; 75(1):16-21. PubMed ID: 25381154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into optic pathway glioma vision loss from mouse models of neurofibromatosis type 1.
    Freret ME; Gutmann DH
    J Neurosci Res; 2019 Jan; 97(1):45-56. PubMed ID: 29704429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
    Solga AC; Gianino SM; Gutmann DH
    Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective cAMP generation underlies the sensitivity of CNS neurons to neurofibromatosis-1 heterozygosity.
    Brown JA; Gianino SM; Gutmann DH
    J Neurosci; 2010 Apr; 30(16):5579-89. PubMed ID: 20410111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of coexisting genetic mutations on murine optic glioma biology.
    Kaul A; Toonen JA; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 May; 17(5):670-7. PubMed ID: 25246427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased c-Jun-NH2-kinase signaling in neurofibromatosis-1 heterozygous microglia drives microglia activation and promotes optic glioma proliferation.
    Daginakatte GC; Gianino SM; Zhao NW; Parsadanian AS; Gutmann DH
    Cancer Res; 2008 Dec; 68(24):10358-66. PubMed ID: 19074905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Akt- or MEK-mediated mTOR inhibition suppresses Nf1 optic glioma growth.
    Kaul A; Toonen JA; Cimino PJ; Gianino SM; Gutmann DH
    Neuro Oncol; 2015 Jun; 17(6):843-53. PubMed ID: 25534823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA Sequencing of Tumor-Associated Microglia Reveals Ccl5 as a Stromal Chemokine Critical for Neurofibromatosis-1 Glioma Growth.
    Solga AC; Pong WW; Kim KY; Cimino PJ; Toonen JA; Walker J; Wylie T; Magrini V; Griffith M; Griffith OL; Ly A; Ellisman MH; Mardis ER; Gutmann DH
    Neoplasia; 2015 Oct; 17(10):776-88. PubMed ID: 26585233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced striatal dopamine underlies the attention system dysfunction in neurofibromatosis-1 mutant mice.
    Brown JA; Emnett RJ; White CR; Yuede CM; Conyers SB; O'Malley KL; Wozniak DF; Gutmann DH
    Hum Mol Genet; 2010 Nov; 19(22):4515-28. PubMed ID: 20826448
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurofibromatosis type 1-associated optic pathway gliomas: pathogenesis and emerging treatments.
    Amato A; Imbimbo BP; Falsini B
    Eur Rev Med Pharmacol Sci; 2023 Jun; 27(12):5636-5653. PubMed ID: 37401302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
    Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
    Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optic nerve dysfunction in a mouse model of neurofibromatosis-1 optic glioma.
    Hegedus B; Hughes FW; Garbow JR; Gianino S; Banerjee D; Kim K; Ellisman MH; Brantley MA; Gutmann DH
    J Neuropathol Exp Neurol; 2009 May; 68(5):542-51. PubMed ID: 19525901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural characterization of the optic pathway in a mouse model of neurofibromatosis-1 optic glioma.
    Kim KY; Ju WK; Hegedus B; Gutmann DH; Ellisman MH
    Neuroscience; 2010 Sep; 170(1):178-88. PubMed ID: 20600672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.
    Diggs-Andrews KA; Brown JA; Gianino SM; Rubin JB; Wozniak DF; Gutmann DH
    Ann Neurol; 2014 Feb; 75(2):309-16. PubMed ID: 24375753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.
    Anderson DM; Van de Plas R; Rose KL; Hill S; Schey KL; Solga AC; Gutmann DH; Caprioli RM
    J Proteomics; 2016 Oct; 149():77-84. PubMed ID: 26883872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.
    Bajenaru ML; Hernandez MR; Perry A; Zhu Y; Parada LF; Garbow JR; Gutmann DH
    Cancer Res; 2003 Dec; 63(24):8573-7. PubMed ID: 14695164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal, spatial, and genetic constraints contribute to the patterning and penetrance of murine neurofibromatosis-1 optic glioma.
    Brossier NM; Thondapu S; Cobb OM; Dahiya S; Gutmann DH
    Neuro Oncol; 2021 Apr; 23(4):625-637. PubMed ID: 33080011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.